Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.
Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page
- Check7 days agoChange DetectedRevision changed from v3.3.3 to v3.3.4; no study content or data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a Maryland location under a new Locations section and updated to revision v3.3.3; removed the Maryland Locations entry and the HHS Vulnerability Disclosure link.SummaryDifference0.2%
- Check57 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2. No substantive changes to the study details are evident.SummaryDifference0.1%
- Check64 days agoChange DetectedThe notice about potential delays due to lapse in government funding has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check79 days agoChange DetectedNo significant changes detected in the study record; observed updates are limited to minor formatting and non-critical textual edits that do not affect eligibility, endpoints, or trial status, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check107 days agoChange DetectedPage now includes a government-funding notice about possible delays and updated operating status links, and the version has been upgraded to v3.2.0 (removing v3.1.0).SummaryDifference2%
Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.